Latham & Watkins Advises TransUnion in US$1.7 Billion Sale of TransUnion Healthcare to nThrive

TransUnion (NYSE: TRU) has announced that it has signed a definitive agreement to sell TransUnion Healthcare, Inc. to nThrive, Inc., a leading healthcare revenue cycle management software-as-a-service platform backed by Clearlake Capital Group, L.P. The transaction consideration is US$1.735 billion in cash. The parties are targeting to close the transaction in the fourth quarter of 2021, subject to the satisfaction of customary closing conditions and regulatory approvals.

Latham & Watkins LLP represents TransUnion in the transaction with a M&A deal team led by Chicago partners Jonathan Solomon and Nathan Davis, with associates William Nahill, Tyler Neal, Tara Nair, Dalton Powell, and Jay Trewn. Advice was also provided on securities law matters by Chicago partners Cathy Birkeland and Alexa Berlin, with associate Ryan Hudson; on executive compensation, employment, and benefits matters by Los Angeles partner David Taub and Chicago partner Nineveh Alkhas, with associate Harrison Taylor; on intellectual property matters by New York partner Jeffrey Tochner, with associates Pelin Serpin and Nancy Zhu; on tax matters by Chicago partner Rene de Vera, with associate Ariel Redlich; on data privacy and security matters by Washington, D.C. partner Jennifer Archie, with associate James Smith; on finance matters by Washington, D.C. partner Jennifer Van Driesen; on environmental matters by Chicago partner Karl Karg; on real estate matters by associate John Jefferson; on antitrust matters by Washington, D.C. partner Amanda Reeves and Washington, D.C. counsel Patrick English, with associate Sophia Bertran; on compliance matters by Chicago partner Meredith Monroe, with associate Andrew Galdes; and on healthcare compliance matters by Bay Area counsels Betty Pang and Heather Deixler, with associates Yanyan Zhou, Felicia Alexander, Leia Gu, Samuel Wang, and Chad Leiper.